The Basics of Cancer Immunotherapy

This comprehensively updated new edition provides patients and their physicians (especially non-oncologist healthcare providers) with a clear and concise introduction to cancer immunotherapy. Unlike traditional forms of cancer therapy, immunotherapy acts by boosting the patient’s own immune system t...

Full description

Saved in:
Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Dong, Haidong (Editor), Markovic, Svetomir N. (Editor)
Format: Electronic eBook
Language:English
Published: Cham : Springer International Publishing : Imprint: Springer, 2024.
Edition:2nd ed. 2024.
Subjects:
Online Access:https://doi.org/10.1007/978-3-031-59475-5
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000nam a22000005i 4500
001 978-3-031-59475-5
003 DE-He213
005 20260904080836.0
007 cr nn 008mamaa
008 240705s2024 sz | o |||| 0|eng d
020 |a 9783031594755  |9 978-3-031-59475-5 
024 7 |a 10.1007/978-3-031-59475-5  |2 doi 
050 4 |a RM270-282 
072 7 |a MJCM  |2 bicssc 
072 7 |a MED044000  |2 bisacsh 
072 7 |a MJCM  |2 thema 
082 0 4 |a 615.37  |2 23 
082 0 4 |a 571.96  |2 23 
245 1 4 |a The Basics of Cancer Immunotherapy  |h [electronic resource] /  |c edited by Haidong Dong, Svetomir N. Markovic. 
250 |a 2nd ed. 2024. 
264 1 |a Cham :  |b Springer International Publishing :  |b Imprint: Springer,  |c 2024. 
300 |a 1 online resource (XIII, 221 p. 20 illus.).  |b 19 illus. in color. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
341 0 |b Table of contents navigation  |2 onix 
341 0 |b Single logical reading order  |2 onix 
341 0 |b Short alternative textual descriptions  |2 onix 
341 0 |b Use of colour is Not sole means of conveying information  |2 onix 
341 0 |b Use of high contrast between text and background colour  |2 onix 
341 0 |b Next / Previous structural navigation  |2 onix 
341 0 |b All Non-decorative content supports reading without sight  |2 onix 
347 |a text file  |b PDF  |2 rda 
505 0 |a The basic concepts in cancer immunology and immunotherapy -- Immune checkpoint inhibitors in oncology -- Bi-specific, T cell engaging antibodies including Tebentifusp -- Cell therapy for cancer: CAR-T, TIL -- Viral immunotherapy strategies in clinical practice: TVEC -- Chemotherapy for resistant cancer to ICI -- Radio-immunotherapy for refractory cancers -- Immunotherapy for melanoma and skin cancer -- Immunotherapy for lung cancer -- Immunotherapy for breast cancer -- Immunotherapy for genitourinary malignancies -- Immunotherapy for gastrointestinal malignancies -- Immunotherapy in the solid organ transplant recipient -- Management of immune-related adverse events from immune checkpoint inhibitor therapy -- Resources for patients undergoing immune therapy for cancer -- Immunotherapy for head and neck cancer. 
520 |a This comprehensively updated new edition provides patients and their physicians (especially non-oncologist healthcare providers) with a clear and concise introduction to cancer immunotherapy. Unlike traditional forms of cancer therapy, immunotherapy acts by boosting the patient’s own immune system to fight cancer; immunotherapy's unique features make its management, monitoring and side-effects different from those of traditional cancer therapy. Especially novel are the side effects of cancer immunotherapy, necessitating greater awareness for both patients and physicians in order to minimize complications and maximize benefits. The patient-friendly and state-of-the-art knowledge presented in this book will inform patients and their care providers about the benefits and risks of cancer immunotherapy, and help them to understand how immunotherapy would control their unique disease. Researchers and academic professionals in the field of cancer immunotherapy will also find clear, useful information to help them communicate with patients and address unresolved issues. Key features include: Expertise. Editors and authors are scientists and oncologists specializing in cancer immunotherapy, involved in scientific discovery from the early stage of immune-checkpoint inhibitors to today's patient care. Their insights, expertise and experience guarantee high quality and authority in the science, medicine and practice of cancer immunotherapy. Patient-friendly. This book is written specifically for cancer patients considering or undergoing immunotherapy. As an educational tool, this book will help the reader to understand the underlying science, balance the risks and benefits based on both research and clinical facts, and make an informed decision regarding their treatment options. Disease Specificity. Cancer is a complicated disease involving multiple stages and pathology. Its response to immunotherapy is individualized and varies depending on cancer types. The authors’ expertise in treating different types of cancers, including melanoma, lung, kidney, bladder, breast, and lymphoma, provides disease-specific insights in applying immunotherapy to each disease. State-of-the-Art. This edition has been comprehensively updated to reflect recent advances, including detailed coverage of the latest therapies like CAR-T, TIL, immune checkpoint inhibitors and bispecific T cell engaging antibodies, and dedicated chapters on breast cancer, solid organ transplant recipients, GI and genitourinary malignancies, and resistant cancer. . 
532 8 |a Accessibility summary: This PDF does Not fully comply with PDF/UA standards but does include limited screen reader support, descriptions for Non-text content (such as images and graphs), bookmarks for easy navigation, and searchable, selectable text. Users of assistive technologies may experience difficulty navigating or interpreting content in this document. We recognise the importance of accessibility and welcome queries about accessibility for any of our products. If you have a question or an access need, please get in touch with us via https://www.springernature.com/gp/info/accessibility 
532 8 |a Inaccessible, or known limited accessibility 
532 8 |a No reading system accessibility options actively disabled 
532 8 |a Publisher contact for further accessibility information: accessibilitysupport@springernature.com 
588 |a Print version record. 
650 0 |a Immunotherapy. 
650 0 |a Medical sciences. 
650 0 |a Immunology. 
650 0 |a Cancer  |x Treatment. 
650 0 |a Patient education. 
650 1 4 |a Immunotherapy. 
650 2 4 |a Health Sciences. 
650 2 4 |a Immunology. 
650 2 4 |a Cancer Therapy. 
650 2 4 |a Patient Education. 
700 1 |a Dong, Haidong.  |e editor.  |0 (orcid)0000-0002-5782-2983  |1 https://orcid.org/0000-0002-5782-2983  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Markovic, Svetomir N.  |e editor.  |0 (orcid)0000-0002-9238-4325  |1 https://orcid.org/0000-0002-9238-4325  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer Nature eBook 
776 0 8 |i Printed edition:  |z 9783031594748 
776 0 8 |i Printed edition:  |z 9783031594762 
856 4 0 |u https://doi.org/10.1007/978-3-031-59475-5 
912 |a ZDB-2-SBL 
912 |a ZDB-2-SXB 
950 |a Biomedical and Life Sciences (SpringerNature-11642) 
950 |a Biomedical and Life Sciences (R0) (SpringerNature-43708)